Pat O’Sullivan
Direttore operativo presso AMICUS THERAPEUTICS, INC.
Provenienza dei contatti di primo grado di Pat O’Sullivan
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Pat O’Sullivan tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| AVON PRODUCTS, INC. | Household/Personal Care | Comptroller/Controller/Auditor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Secretary Compliance Officer | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director of Finance/CFO | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| SANOFI | Biotechnology | Investor Relations Contact | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | Biotechnology | President President | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| The University of Manchester | College/University | Graduate Degree | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Novazyme Pharmaceuticals, Inc.
 Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| Monmouth University | College/University | Undergraduate Degree | |
| Oregon State University | College/University | Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Doctorate Degree | |
Make-A-Wish Foundation of America
 Make-A-Wish Foundation of America Miscellaneous Commercial ServicesCommercial Services Make-A-Wish Foundation of America operates as a charitable organization. It serves child diagnosed with a life-threatening medical condition. The company was founded by Allan Schmidt, Kathy McMorris, and Tommy Austin in 1980 and is headquartered in Phoenix, AZ. | Miscellaneous Commercial Services | Chairman Chairman | |
| L'Université d'Angers | College/University | Doctorate Degree | |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Institute of Management Accountants, Inc.
 Institute of Management Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Institute of Management Accountants, Inc. provides accountants and financial services. The company was founded in 1919 and is headquartered in Montvale, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Director/Board Member | |
| Burgundy School of Business | College/University | Graduate Degree | |
| AMYLYX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Ethismos Research, Inc.
 Ethismos Research, Inc. BiotechnologyHealth Technology Ethismos Research, Inc. is a clinical-stage drug development company located in an undisclosed location. Ethismos is developing pharmaceutical treatments for pain, depression, and substance use disorders. Amitifadine is different from opioids and addiction treatments because it is not believed to be addictive, nor is it a stimulant or an opioid. Ethismos plans to commence phase 2 amitifadine clinical trials for opioid-sparing and facilitation of opioid taper as a non-opioid analgesic in chronic pain patients treated with long-term opioids. The American company is also exploring amitifadine trials in depression maintenance post-ketamine treatment, methamphetamine dependence, and nicotine cessation. The private company was founded by Anthony A. McKinney and he has been the CEO since incorporation. The company is continuing the development of the patented small molecule, amitifadine, a triple reuptake inhibitor, originally developed by euthymics bioscience, and acquired by ethismos in 2017. | Biotechnology | Founder | |
| CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Headwaters Biotech Advisors LLC | Chief Executive Officer | ||
| GEORGIA PUBLIC HEALTH ASSOCIATION, INC. | Chairman | ||
Therapeutics, Inc.
 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Therapeutics, Inc. is a dermatology CRO that specializes in moving products from concept to commercialization. The private company is based in Reston, VA. The company collaborates with clients to expertly design, create, and execute development programs for FDA registration of topical, oral, and injectable drugs, biologics, and devices. The company's services address all aspects needed for a dermatology CRO, from product development to clinical development and regulatory affairs. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 41 |
| Regno Unito | 5 |
| Francia | 5 |
| India | 2 |
| Svezia | 2 |
Settori
| Health Technology | 27 |
| Consumer Services | 13 |
| Commercial Services | 9 |
| Consumer Non-Durables | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 132 |
| Corporate Officer/Principal | 66 |
| Independent Dir/Board Member | 43 |
| Undergraduate Degree | 27 |
| President | 26 |
Contatti più connessi
| Insiders | |
|---|---|
| Burke Whitman | 21 |
| Mike Raab Raab | 20 |
| John Crowley | 19 |
| Sandy Smith | 19 |
| Michael Kelly | 19 |
| Lynn Bleil | 16 |
| Glenn Sblendorio | 15 |
| Francois-Xavier Duhalde | 14 |
| Margaret McGlynn | 14 |
| Richard A. Moscicki | 13 |
| Bradley Campbell | 13 |
| Craig Wheeler | 12 |
| Anthony A. McKinney | 11 |
| Susan Moran | 10 |
| Simon Harford | 9 |
- Borsa valori
- Insiders
- Pat O’Sullivan
- Connessioni Società
